Goldman Sachs’s Acadia Healthcare ACHC Stock Holding History

Goldman Sachs’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-44,500	Closed	-$1.57M	–	5191
2018 Q3	$1.57M	Buy	+44,500	New	+$1.77M	﹤0.01%	3753
2017 Q3	–	Sell	-66,400	Closed	-$3.28M	–	6630
2017 Q2	$3.28M	Sell	66,400 -32,500	-33%	-$1.44M	﹤0.01%	3415
2017 Q1	$4.31M	Sell	98,900 -25,500	-20%	-$1.03M	﹤0.01%	3061
2016 Q4	$4.12M	Buy	124,400 +30,200	+32%	+$1.17M	﹤0.01%	3212
2016 Q3	$4.67M	Buy	94,200 +50,000	+113%	+$2.6M	﹤0.01%	3099
2016 Q2	$2.45M	Buy	44,200 +19,200	+77%	+$1.12M	﹤0.01%	3438
2016 Q1	$1.38M	Buy	+25,000	New	+$1.43M	﹤0.01%	3805
2015 Q4	–	Sell	-5,000	Closed	-$331K	–	7113
2015 Q3	$331K	Sell	5,000 -2,500	-33%	-$192K	﹤0.01%	5515
2015 Q2	$587K	Sell	7,500 -19,500	-72%	-$1.4M	﹤0.01%	5018
2015 Q1	$1.93M	Buy	27,000 +2,500	+10%	+$160K	﹤0.01%	3817
2014 Q4	$1.5M	Buy	+24,500	New	+$1.43M	﹤0.01%	4141

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Goldman Sachs's ACHC Position: Q2 2026 in Review

Goldman Sachs increased its Acadia Healthcare (ACHC) stake by 28% in Q2 2026, buying an estimated $16.2M and bringing the position to 2,872,128 shares worth $84.8M. The position accounts for 0.01% of the portfolio, ranked #1358.

Goldman Sachs first reported a position in ACHC in Q2 2013 and has held it in 53 quarters since. The position peaked at $216M in Q2 2017. 313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

Goldman Sachs held 2,872,128 shares of Acadia Healthcare worth $84.8M as of Q2 2026.
Goldman Sachs bought 631,700 Acadia Healthcare shares in Q2 2026, an estimated $16.2M.
Acadia Healthcare made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1358 holding.
Goldman Sachs first reported a position in Acadia Healthcare in Q2 2013 and has held it in 53 quarters since.
Goldman Sachs's Acadia Healthcare position peaked at $216M in Q2 2017.
313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.